Altre lingue CEL-SCI Corporation

Azioni

CVM

US1508376076

Mercato chiuso - Nyse Altri mercati azionari 22:00:00 06/05/2024			Variaz. 5gg	Var. 1 gen.
1,72 ^USD	+5,52%		+21,99%	-36,76%

23/04	CEL-SCI Corporation nomina Mario Gobbo nel Consiglio di Amministrazione	CI
14/02	CEL-SCI Corporation riporta i risultati degli utili per il primo trimestre conclusosi il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

CEL-SCI Appoints Mario Gobbo to Its Board of Directors	23/04
CEL-SCI Corporation Appoints Mario Gobbo as Board of Directors	23/04
CEL-SCI’s LEAPS Vaccine Offers Promising New Paradigm to Treat Rheumatoid Arthritis: Published in Frontiers in Immunology	19/03
CEL-SCI Corporation Issues Letter to Shareholders	06/03
CEL-SCI Corporation Reports First Quarter Fiscal 2024 Financial Results	15/02
Cel-Sci: Fiscal Q1 Earnings Snapshot	14/02
CEL-SCI Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023	14/02
CEL-SCI Corporation (von First Berlin Equity Research GmbH...	14/02
Cel-Sci Closes $7.8 Million Share Offering	13/02
CEL-SCI Announces Closing of $7.75 Million Public Offering of Common Stock	13/02
CEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stock	12/02
Health Care Slips on Rotation to High-Risk Sectors -- Health Care Roundup	10/02
Cel-Sci Prices $7.8 Million Public Offering of Common Shares	09/02
CEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stock	09/02
CEL-SCI Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head and Neck Cancer Drug	07/02
CEL-SCI Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head & Neck Cancer Drug	06/02
CEL-SCI Corporation Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head & Neck Cancer Drug	06/02
European Medicines Agency Grants CEL-SCI a Waiver of Strict Pediatric Requirements, Clearing the Path towards Marketing Authorization for Multikine	01/02
Sector Update: Health Care Stocks Mixed Late Wednesday Afternoon	31/01
Sector Update: Health Care Stocks Gain in Afternoon Trading	31/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue CEL-SCI Corporation

Azioni

CVM

US1508376076

Altre lingue

Filtri